Skip to main content
    C

    Celularity Inc (CELUW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.00
    +0.00 (+0.00%)

    Last updated: Jul 23, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 21
    Reported Sep 30
    		$0.40$0.00N/ABeat+115.9%
    Mar 21
    Reported Jun 30
    		$-2.69$0.00N/AMiss+52.5%
    Dec 20
    Reported Mar 31
    		$-3.40$0.00N/AMiss-169.6%
    Sep 20
    Reported Dec 31
    		$0.16$0.00N/ABeat+117.6%
    Jun 20
    Reported Sep 30
    		$-2.52$0.00N/AMiss-
    Mar 20
    Reported Jun 30
    		$-5.66$0.00N/AMiss-
    Dec 19
    Reported Mar 31
    		$-1.26$0.00N/AMiss-
    Sep 19
    Reported Dec 31
    		$-0.93$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-492.10%
    ROE-6367.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.54Avg VolumeN/A
    52-Week High$0.0652-Week Low$0.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.00
    SMA 20$0.00
    SMA 50$0.00
    SMA 200$0.01
    EMA 10$0.00
    EMA 20$0.00
    EMA 50$0.00
    EMA 200$0.01

    MACD

    Line: -0.00Signal: -0.00Hist: N/A

    ADX

    ADX: 53.3+DI: 9.5-DI: 36.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down80.0
    PSAR$0.00

    Bollinger Bands

    Upper Band$0.01
    Lower Band$-0.00
    %B Position20947%(Upper)
    Band Width0.35

    RSI (14-Day)

    Neutral
    41.9

    Momentum Oscillators

    Stoch %K35.4
    Stoch %D35.4
    Williams %R-64.6
    ROC (10d)-51.3%
    Momentum-0.00
    CCI (20d)-51.8
    MFI (14d)33.6

    Volatility Measures

    ATR (14d)$0.00(59.9%)
    StdDev (20d)0.00
    Hist Vol1990.1%(High)

    Volume Flow

    VWAP$0.00
    OBV-1.1M
    AD Line-4.5K
    CMF (20d)-0.204

    Volume Metrics

    Avg Vol (20d)127.9K
    Vol RatioN/A
    VWMA (20d)$0.00

    Pivot Points

    R3$0.00
    R2$0.00
    R1$0.00
    Pivot Point$0.00
    S1$0.00
    S2$0.00
    S3$0.00

    Advanced Oscillators

    TSI-20.19
    Ultimate Osc47.7
    KST-616.51

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$4.10M$4.10M$5.28M$5.74M$18.13M$18.13M$9.30M$12.11M$14.68M$3.79M$3.79M$2.94M
    Cost of Revenue$-4,452,000$7.37M$2.02M$5.24M$7.34M$7.34M$3.88M$9.61M$1.64M$3.60M$3.60M$802,000
    Gross Profit$8.56M$-3,270,000$3.27M$494,000$10.79M$10.79M$5.41M$2.50M$13.04M$184,000$184,000$2.14M
    Operating Expenses$30.61M$26.16M$16.17M$16.36M$20.07M$27.61M$16.94M$-10,812,000$22.06M$99.44M$20.09M$44.61M
    R&D$3.35M$3.35M$4.60M$3.35M$3.83M$3.83M$3.92M$108.07M$5.84M$5.18M$5.18M$8.60M
    SG&A$0$15.06M$9.31M$12.63M$16.04M$16.06M$12.65M$13.02M$14.03M$13.07M$10.75M$12.83M
    Operating Income$-22,058,000$-22,058,000$-12,900,000$-15,864,000$-9,280,000$-9,473,000$-11,527,000$13.31M$-7,376,000$-99,256,000$-16,299,000$-42,476,000
    Interest Income$0$62,000$62,000$62,000$76,000$77,000$77,000$67,000$110,000$115,000$23,000$66,000
    Interest Expense$897,000$897,000$1.48M$1.94M$1.81M$1.81M$1.75M$663,000$1.15M$971,000$971,000$1.10M
    Income Before Tax$-24,359,000$-24,359,000$-23,076,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.56M$-22,013,000$-93,876,000$-93,876,000$-47,949,000
    Income Tax Expense$3,000$0$-3,000$0$13.49M$0$-13,489,000$10,000$0$2.11M$0$-3,197,000
    Net Income$-24,362,000$-24,362,000$-23,073,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.55M$-22,013,000$-93,876,000$-93,876,000$-47,949,000
    EBITDA$-21,659,000N/A$-19,733,000$-20,747,000$-7,597,000N/A$-12,452,000$-8,550,000N/A$-90,562,000N/A$-44,523,000
    EBIT$-23,462,000N/A$-21,599,000$-22,581,000$-9,473,000N/A$-14,346,000$-10,846,000N/A$-92,905,000N/A$-46,845,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CELUW

    News

    No news available

    Company news will appear here when available

    CELUW Profitability: Margins, ROIC and FCF

    Operating margin
    -492.1%
    Net margin
    0.0%
    ROE
    -6367.0%

    CELUW Competitors

    CompanyTicker
    Biofrontera Inc. WarrantsBFRIW
    P3 Health Partners IncPIIIW
    NRx Pharmaceuticals IncNRXPW
    NeuroSense Therapeutics Ltd. WarrantNRSNW
    China SXT Pharmaceuticals IncSXTC
    Protagenic Therapeutics IncPTIXW
    ProPhase Labs IncPRPH
    Jasper Therapeutics IncJSPRW

    Sector: Healthcare

    CELUW Bull Case vs Bear Case

    Bear case

    • CELUW beat EPS estimates in 25.0% of its last 8 reported quarters.
    • CELUW's quarterly revenue changed -77.4% year over year.

    CELUW Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)

    Frequently Asked Questions About CELUW

    Does CELUW pay dividends?

    Celularity Inc (CELUW) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In